Brief: Next Science Posts 1H23 Underlying EBITDA Loss Of $8.3M

Next Science

31/08/2023 02:25

Aug 31 (Reuters) - Next Science Ltd  NXS.AX :
    * 1HFY23 UNDERLYING EBITDA LOSS OF US$8.3M V US$6.6M PCP
    * 1HFY23 PRODUCT SALES INCREASED 92%YOY TO US$10.0M
    * REVENUE FOR 2HFY23 EXPECTED TO BE BETWEEN US$16M AND
US$19M
    * POSITIVE EBITDA AND CASHFLOW EXPECTED DURING 2HFY24
    * SHARE PURCHASE PLAN TO BE LAUNCHED ON 1 SEPTEMBER TO RAISE
UP TO
AN ADDITIONAL A$5M (BEFORE COSTS)

Source text for Eikon:  ID:nASX5gKrTC 
Further company coverage:  NXS.AX 

 ((Reuters.Briefs@thomsonreuters.com;))